Interview: Hemogenyx

This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator

The Hemogenyx breakthrough heralds the double whammy of the end of chemotherapy and the need for bone marrow transplants to treat blood diseases, as well as a new investment situation.

Dr. Vladislav Sandler is the founder and CEO of Hemogenyx and Adrian Beestan, Director at Hemogenyx Pharmaceuticals talk to host Zak Mir about the company’s mission.

 

[youtube https://www.youtube.com/watch?v=6kG7G_Hwo9U&w=560&h=315]
Zak Mir

Zak Mir

About Me

Zak Mir is a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator. Zak presents the daily Bulletin Board Heroes which can be seen here at Share Talk

Recent Posts

Zak Mir Twitter

RT @ShareTalkNews: Remote Monitored Sys (#RMS.L) Shareholders’ Questions and Answers. If shareholders have any further... Read More

Aug 03 2021, 3:06 pm

RT @iap243542: #ORCP Let’s hope pressure from local government , energy demand , C2L... Read More

Aug 03 2021, 2:04 pm

RT @Share_Talk: Online threat hunter @BrandShieldltd (#BRSD.L) continues to roll out new contracts, with the... Read More

Aug 03 2021, 1:57 pm

Bulliten Board Heroes

Malcare WordPress Security